✉news HealthMedicine first seen 8 h ago, last 8 h ago, peak #33
Microdosing GLP-1s: what patients should know
Original: Microdosing GLP-1s, explained: what it is, why it's trending, and what an obesity medicine doctor wants patients to know
Some patients taking GLP-1 weight-loss drugs such as Ozempic and Wegovy are experimenting with microdosing, using lower doses than prescribed, often to cut costs or reduce side effects. An obesity medicine doctor is explaining what the practice involves and urging caution, since evidence for smaller-than-approved doses is limited and self-adjusting medication without medical supervision carries risks.
Why now: GLP-1 drugs are hugely popular and rising costs and side effects are driving interest in taking smaller doses.
GLP-1 drugsOzempicWegovyobesity medicine doctors
Evidence
- Microdosing GLP-1s, explained: what it is, why it's trending, and what an obesity medicine doctor wants patients to know · Yahoo Creators
API: https://socialmediatrends-api.osmike.com/v1/trends/615512